- ICH GCP
- Реестр клинических исследований ЕС
Последние исследования
EudraCT Number: 2004-002208-14 | Sponsor Protocol Number: Protocol v.1.2 30/08/04 | Start Date: 2005-02-21 | ||||||
Sponsor Name: Cardiff and Vale NHS Trust | ||||||||
Full Title: Duration of Amiodarone therapy required for new post cardiac surgery atrial fibrillation. | ||||||||
Medical condition: Atrial fibrillation following cardiac surgery. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Prematurely Ended) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004267-30 | Sponsor Protocol Number: Gebro-III-21-10 | Start Date: 2005-02-21 | ||||||
Sponsor Name: Gebro Pharma GmbH | ||||||||
Full Title: Efficacy and Tolerability of Dexibuprofen Film coated tablets in Comparison to Ibuprofen in Children and Adolescents with Tonsillopharyngitis | ||||||||
Medical condition: Tonsillopharyngitis | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-004748-27 | Sponsor Protocol Number: Acadmed CTU01/05 | Start Date: 2005-02-21 | |||||||||||
Sponsor Name: Hull and east Yorkshire Hospitals Trust, Research and Deveopment, admin porta cabin | |||||||||||||
Full Title: An 8 week, double-blind, randomised, parallel group study to investigate the effect of 20 mg Esomeprazole (Nexium) tablets Twice daily versus placebo on symptoms associated with chronic cough due ... | |||||||||||||
Medical condition: We will be using Nexium to treat gastro-oesophageal reflux and in return this will reduce reflux related cough ( a manifestation of reflux) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004339-78 | Sponsor Protocol Number: FOLFOX6 | Start Date: 2005-02-18 | |||||||||||
Sponsor Name: AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: FOLFOX6 TRIAL: TREATMENT OF THE FIRST LINE OF LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER. CLINICAL TRIAL ABOUT BIOMOLECULAR PREDICTIVE FACTORS | |||||||||||||
Medical condition: Locally Advanced and Metastatic Gastric Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002945-10 | Sponsor Protocol Number: V501-020 | Start Date: 2005-02-18 | |||||||||||
Sponsor Name: Suomen MSD OY | |||||||||||||
Full Title: A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16, and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related Anogenital Warts, and the I... | |||||||||||||
Medical condition: Prevention of Human Papillomavirus Infections | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) DE (Completed) ES (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001729-11 | Sponsor Protocol Number: CR040301 | Start Date: 2005-02-18 | |||||||||||
Sponsor Name: EBEWE Pharma Ges.m.b.H Nfg.KG | |||||||||||||
Full Title: A prospective, randomised, placebo controlled, double blind trial about safety and efficacy of combined treatment with Alteplase (rt-PA) and Cerebrolysin in acute ischemic hemispheric stroke | |||||||||||||
Medical condition: Clinical diagnosis of ischemic stroke causing a measurable neurological deficit defined as impairment of language, motor function, cognition and/or gaze, vision or neglect. Ischemic stroke is defin... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) SK (Completed) CZ (Completed) SI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002165-20 | Sponsor Protocol Number: 20040110 | Start Date: 2005-02-18 | ||||||
Sponsor Name: Amgen Inc | ||||||||
Full Title: An open label study of AMG 706 in subjects with advanced gastrointestinal stromal tumors (GISTs) who developed progressive disease or relapsed while on Imatinib Mesylate. | ||||||||
Medical condition: Gastrointestinal stromal tumour (GIST) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) DE (Completed) IT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002798-21 | Sponsor Protocol Number: WI18273 | Start Date: 2005-02-18 | ||||||
Sponsor Name: F.Hoffmann-La Roche Ltd | ||||||||
Full Title: A Phase II, prospective, randomized, double-blind, active-controlled, parallel group, multi-center 'proof of concept' trial in adult patients with community-acquired pneumonia requiring hospitaliza... | ||||||||
Medical condition: Community-acquired pneumonia | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: LV (Completed) HU (Completed) SK (Completed) LT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-005045-35 | Sponsor Protocol Number: CLAF237A2327 | Start Date: 2005-02-17 | ||||||
Sponsor Name: Novartis Sverige AB | ||||||||
Full Title: A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with LAF237 50 mg bid to rosiglitazone 8 mg qd in drug naïve patients with type 2 diabetes | ||||||||
Medical condition: Type II Diabetes | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: SE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002102-30 | Sponsor Protocol Number: CC-5013-MM-012 | Start Date: 2005-02-17 | |||||||||||
Sponsor Name: CELGENE EUROPE LIMITED | |||||||||||||
Full Title: OPEN-LABEL, SINGLE-ARM STUDY OF THE SAFETY AND EFFICACY OF CC-5013 MONOTHERAPY FOR SUBJECTS WITH MULTIPLE MYELOMA A COMPANION STUDY FOR STUDIES THAL-MM-003, CC-5013-MM-009, AND CC-5013-MM-010 | |||||||||||||
Medical condition: Multiple Myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |